
Sign up to save your podcasts
Or


In this episode of Practice Pearls: Overcoming Therapeutic Inertia Dr. Andrew Bzowyckyj discusses overcoming resistance to treatment intensification. This is part of the American Diabetes Association’s Overcoming Therapeutic Inertia initiative supported by Strategic Sponsors AstraZeneca and Sanofi, plus Supporting Sponsors Merck and Novo Nordisk.
This episode is sponsored by the Overcoming Therapeutic Inertia Initiative - for more information about resources for overcoming therapeutic inertia, just go to www.TherapeuticInertia.diabetes.org
Presented by:
Andrew Bzowyckyj, PharmD, BDPS, CDCES, Associate Professor, Pacific University Oregon
Neil Skolnik, M.D. , Professor of Family and Community Medicine, Sidney Kimmel Medical College, Thomas Jefferson University, Associate Director, Family Medicine Residency Program, Abington Jefferson Health
By American Diabetes Association4.5
9696 ratings
In this episode of Practice Pearls: Overcoming Therapeutic Inertia Dr. Andrew Bzowyckyj discusses overcoming resistance to treatment intensification. This is part of the American Diabetes Association’s Overcoming Therapeutic Inertia initiative supported by Strategic Sponsors AstraZeneca and Sanofi, plus Supporting Sponsors Merck and Novo Nordisk.
This episode is sponsored by the Overcoming Therapeutic Inertia Initiative - for more information about resources for overcoming therapeutic inertia, just go to www.TherapeuticInertia.diabetes.org
Presented by:
Andrew Bzowyckyj, PharmD, BDPS, CDCES, Associate Professor, Pacific University Oregon
Neil Skolnik, M.D. , Professor of Family and Community Medicine, Sidney Kimmel Medical College, Thomas Jefferson University, Associate Director, Family Medicine Residency Program, Abington Jefferson Health

321 Listeners

702 Listeners

503 Listeners

1,723 Listeners

872 Listeners

905 Listeners

3,366 Listeners

1,147 Listeners

45 Listeners

519 Listeners

366 Listeners

37 Listeners

439 Listeners

11 Listeners

24 Listeners